Pitcairn’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $244K | Sell |
7,737
-1,396
| -15% | -$44K | 0.02% | 621 |
|
2025
Q1 | $299K | Buy |
9,133
+166
| +2% | +$5.44K | 0.02% | 577 |
|
2024
Q4 | $324K | Buy |
8,967
+149
| +2% | +$5.39K | 0.02% | 561 |
|
2024
Q3 | $275K | Sell |
8,818
-1,033
| -10% | -$32.2K | 0.02% | 613 |
|
2024
Q2 | $264K | Buy |
9,851
+668
| +7% | +$17.9K | 0.02% | 620 |
|
2024
Q1 | $313K | Buy |
9,183
+109
| +1% | +$3.72K | 0.02% | 567 |
|
2023
Q4 | $263K | Sell |
9,074
-75
| -0.8% | -$2.17K | 0.02% | 579 |
|
2023
Q3 | $252K | Buy |
9,149
+521
| +6% | +$14.4K | 0.02% | 551 |
|
2023
Q2 | $259K | Sell |
8,628
-64
| -0.7% | -$1.92K | 0.02% | 553 |
|
2023
Q1 | $315K | Sell |
8,692
-176
| -2% | -$6.38K | 0.03% | 475 |
|
2022
Q4 | $316K | Sell |
8,868
-333
| -4% | -$11.9K | 0.03% | 449 |
|
2022
Q3 | $311K | Buy |
9,201
+150
| +2% | +$5.07K | 0.03% | 416 |
|
2022
Q2 | $262K | Buy |
9,051
+52
| +0.6% | +$1.51K | 0.03% | 479 |
|
2022
Q1 | $291K | Buy |
8,999
+523
| +6% | +$16.9K | 0.03% | 508 |
|
2021
Q4 | $247K | Buy |
+8,476
| New | +$247K | 0.02% | 573 |
|
2018
Q3 | – | Sell |
-8,138
| Closed | -$487K | – | 545 |
|
2018
Q2 | $487K | Sell |
8,138
-724
| -8% | -$43.3K | 0.05% | 261 |
|
2018
Q1 | $406K | Buy |
8,862
+392
| +5% | +$18K | 0.04% | 287 |
|
2017
Q4 | $337K | Buy |
8,470
+273
| +3% | +$10.9K | 0.03% | 356 |
|
2017
Q3 | $328K | Sell |
8,197
-40
| -0.5% | -$1.6K | 0.04% | 340 |
|
2017
Q2 | $355K | Sell |
8,237
-731
| -8% | -$31.5K | 0.04% | 303 |
|
2017
Q1 | $281K | Sell |
8,968
-337
| -4% | -$10.6K | 0.03% | 386 |
|
2016
Q4 | $235K | Sell |
9,305
-2,219
| -19% | -$56K | 0.03% | 437 |
|
2016
Q3 | $285K | Sell |
11,524
-403
| -3% | -$9.97K | 0.04% | 384 |
|
2016
Q2 | $243K | Sell |
11,927
-424
| -3% | -$8.64K | 0.03% | 383 |
|
2016
Q1 | $189K | Buy |
+12,351
| New | +$189K | 0.02% | 449 |
|